Cyprotex was acquired by Evotec AG in December 2016. The Investor Relations section has now been removed from the Cyprotex website. Please refer to the Evotec website for future Investor Relations updates.
Please give details of the assays you are interested in. Where appropriate please specify one or more species (human, rat, mouse etc.), isoforms (CYP1A1,CYP1B1, etc) or other relevant details.
If you would like to be kept informed of our latest services, new research, events and other news please tick the box below:
Opt-in to Cyprotex news